Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Daniel Knopp
Introduction
Daniel Knopp is a notable inventor based in Storkow, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in vaccine development. His work focuses on synthetic oligosaccharides that play a crucial role in immunological assays and disease prevention.
Latest Patents
Daniel Knopp holds a patent for a vaccine that relates to a synthetic oligosaccharide of general formula (I): T*-[(—U—U—U—U—U)—(V—V—V)-T-O-L-E. This invention is associated with serotype O3, O3, and/or O5 lipopolysaccharide and its conjugate. The synthetic oligosaccharide and the pharmaceutical composition containing it are useful for the prevention and treatment of diseases linked to these bacteria. Furthermore, this oligosaccharide serves as a marker in immunological assays for detecting antibodies against serotype O3, O3, and/or O5 bacteria. He has 1 patent to his name.
Career Highlights
Daniel Knopp is currently employed at Idorsia Pharmaceuticals Ltd., where he continues to innovate in the field of vaccine research. His work has the potential to impact public health significantly by providing new methods for disease prevention.
Collaborations
Some of his notable coworkers include Arun Naini and Bopanna Monnanda, who contribute to the collaborative efforts in research and development at Idorsia Pharmaceuticals Ltd.
Conclusion
Daniel Knopp's innovative work in vaccine development showcases his commitment to advancing medical science. His contributions are vital for the prevention and treatment of diseases, highlighting the importance of research in public health.